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Abstract 
We present the clinical course of a patient
with human immunodeficiency virus and an
adrenal  adenomatoid  tumor  (AAT).  We
describe the clinical course and laboratory,
radiographic, and microscopic findings of a
patient with human immunodeficiency virus
(HIV) and an adenomatoid tumor of the right
adrenal gland. A review of the literature was
also  done  via  electronic  searches  through
PubMed for articles from 1965 to 2008 that
contained the following search terms, adeno-
matoid tumor limited to the English language
only.  A  22  year-old  African-American  male
with  HIV  was  incidentally  found  to  have  a
hypermetabolic  right  adrenal  mass.    The
patient underwent laparoscopic adrenalecto-
my  and  the  mass  had  morphological  and
immunohistochemical  features  that  were
consistent with an AAT. A review of the med-
ical literature reveals that almost all cases of
AAT  were  in  male  patients  (96%)  with  a
mean age of 41±11 years (range=22-64) with
no significant difference in laterality (right
side=46%,  left  side=50%,  unknown=4%).
AAT  have  an  average  size  of  4.2±3.5  cm
(range=0.5-14.3 cm). Pre-operative imaging
studies do not appear to be able to reliably
distinguish AAT from other types of adreno-
cortical tumors. For reasons that require fur-
ther  research,  AAT  typically  occur  in  male
patients  and  may  be  associated  with
immunosuppression.  AAT  can  be  safely
removed laparoscopically with no evidence of
long-term recurrence even with tumor exten-
sion beyond the adrenal capsule.
Introduction
Adenomatoid tumors most commonly occur
in the genital tract including the epididymis,
uterus, or fallopian tube.1 Interestingly, these
tumors have also been reported to occur in
the  adrenal  gland.1-6 Adrenal  adenomatoid
tumors  are  derived  from  mesothelial  cells
from  mesothelial  rests  within  the  adrenal
gland.  These rests are likely present due to
the close embryological relationship between
the adrenal glands and the Mullerian tract.6-7
This report represents the 29th case of an
adrenal adenomatoid tumor in the literature,
but is only the second case described in a
patient with human immunodeficiency virus
and the first case in which positron emission
tomographic  scanning  was  used  as  part  of
the diagnostic work-up. 
Materials and Methods
We describe the clinical course, laboratory,
radiographic, and microscopic findings of a
patient with human immunodeficiency virus
and an adenomatoid tumor of the right adre-
nal gland. A review of the literature was also
done  via  electronic  searches  through
PubMed for articles from 1965 to 2008 that
contained the following search terms, adeno-
matoid tumor limited to the English language
only.  All  articles  that  contained  reported
cases of adenomatoid tumor were analyzed.
Pertinent references from these articles were
reviewed and synthesized. This cycle contin-
ued until it was felt that a complete listing of
all published cases of adenomatoid tumors in
the  English  language  was  obtained.  This
study  was  approved  by  the  Institutional
Review  Board  at  University  Hospitals  of
Cleveland.
Results
Report of a case
AH is a 22 year-old African-American male
with a past medical history of human immun-
odeficiency  virus  on  HAART  (Highly  Active
Anti-Retroviral  Therapy)  who  was  noted  to
have an incidental adrenal mass on comput-
ed tomography of the chest done as a follow-
up  study  for  mediastinal  lymphadenopathy.
No previous adrenal masses were noted on
previous computed tomographic imaging.  
The patient denied any symptoms of palpi-
tations,  diaphoresis,  flushing,  or  uncon-
trolled high blood pressure. He subsequently
had a magnetic resonance imaging scan to
further characterize the adrenal mass. It was
a right adrenal mass that measured 2.7 by 1.6
by 2.3 cm in size with atypical enhancement
patterns  with  gadolinium  contrast.  The
patient  underwent  a  complete  adrenal  hor-
monal  work-up.    His  24-hour  urine  cate-
cholamines, serum aldosterone, and plasma
renin activity were all normal.  Serum corti-
sol level was mildly elevated, but his urinary
cortisol level was normal.  Prior to surgical
referral, the patient also underwent a follow-
up  positron  emission  tomographic  scan
which demonstrated increased uptake of 3.4
SUV. Based on the above findings, the differ-
ential diagnosis included a non-functioning
adrenal adenoma or malignancy. The patient
underwent a laparoscopic right adrenalecto-
my with no post-operative complications on
follow-up examination seven months later.
Pathologic findings
On gross examination, the adrenal gland
was 5.5 by 3.0 by 1.0 cm in size with a well-
circumscribed,  firm,  tan-gray  cortical  mass
that measured 2.5 by 2.5 by 1.0 cm. No areas
of necrosis or hemorrhage were identified in
the mass.  On light microscopy examination,
the  adrenal  mass  was  composed  of  epithe-
lioid cells forming nests, cords, and tubules.
There  were  no  areas  of  necrosis,  mitotic
activity, or significant atypia. On immmuno-
histochemical examination, the cells in the
adrenal mass were positive for calretinin and
cytokeratins (AE1/3 and CAM 5.2) and nega-
tive for CD31, CD34, and Factor VIII. These
morphological  and  immunohistochemical
features were consistent with an adenoma-
toid tumor (Figures 1-3).
Literature review
As illustrated in Table 1 and 2, there have
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Case Report
Table 2.  Pathological data from review of the medical literature.
# Author Tumor characteristics Tumor extension Histochemistry Electron microscopy
1Evans et al. Tan, smooth with cystic spaces No extension Not stated Numerous slender microvilli, 
desmoslome-like intracellular junctions, 
intracytoplasmic tonofilaments
2Simpsonet al. Fleshy, gray, solid, cystic Extension into peri-adrenal  Positive for antihuman cytokeratin,  Not done
adipose tissue but negative for carcinoembryonic antigen; 
No glycogen or mucin content
3Travis et al. Pale, white, and solid Extension into cortex and  Strongly positive for keratin (AE1/AE3) Tortuous microvilli with a moderate 
periadrenal adipose tissue and vimentin; Weakly positive for epithelial  amount of tonofilaments
membrane antigen
4Raaf et al. White and solid No extension Reacted with MAK-6 and AE1/AE3;  Long, thin, bushy microvilli with well-
Positive staining for vimentin developed desmosomes, basal laminae, 
and cytoplasmic tonofilaments
5Raaf et al. White, solid, firm, and smooth No extension Reacted with MAK-6 and AE1/AE3;  Not done
Positive staining for vimentin
6Raaf et al. White, firm and smooth No extension Not stated Not done
7Raaf et al. White, predominantly cystic No extension Reacted with MAK-6 and AE1/AE3;  Long, thin, bushy microvilli
Positive staining for vimentin with well-developed desmosomes, basal 
laminae, and cytoplasmic tonofilaments
8Angeles-Angeles et al. Ill-defined, white-yellowish,  No extension Stained positive for low molecular weight Not done
and firm nodule cytokeratin CKAE-3 and weakly for vimentin
9Gasque et al. Grayish with pseudocyst No extension Stains positive for cytokeratin (CAM 5.2) Not done
10 Glatz et al. Pale-yellow, spongy, cystic No extension Strongly positive for keratin (Cam 5.2, Lu-5)  Long and slender microvilli 
and calretinin; Weakly positive  Long and slender microvilli
for thrombomodulin.   and abundant desmosomes along
Negative staining for CEA, MOC-31, BerEP4,  luminal surface with bundles
and CD34. of tonofibrils in the cytoplasm
11 Chung-Parket al. Pale-yellow, solid, and firm Extension into adrenal cortx Positive for cytokeratin and calretinin,  Long, busy microvilli with
but negative for synaptophysin,  intracytoplasmic tonofilaments,
chromogranin,  and intercellular desmosomes
factor VIII, CD34, and S-100.
12 Isotalo et al. Solitary and poorly  Extension into peri-adrenal  Strongly positive for calretinin, cytokeratins Not done
circumscribed adipose tissue (AE1/AE3, CAM 5.2, CK7) and vimentin.  
Weakly positive for CK5/CK6.  
Negative for CD15, CD31, CD34, CK20, 
MOC31, and p-CEA.
13 Isotalo et al. Extension into adrenal gland capsule Not done
14 Isotalo et al. Extension into adrenal gland capsule Not done
15 Isotalo et al. Extension into peri-adrenal adipose tissue Not done
16 Kim and Ro Smooth, grayish, white and firm  No extension Stained positive for cytokeratin  Desmosomes. Cytomplasmic fibrillar
with cystic spaces and calretinin networks, and numerous long, bushy, 
microvilli on luminal surfaces
17 Denicol et al. Multicystic, yellow, opaque No extension Stains positive for AE1, AE3, and vimentin Not done
18 Garg et al. Fibrous wall with an intramural  No extension Stains positive for calretinin and focal weak  Numerous 
well-demarcated tumor  staining for cytokeratin 5/6 long, bushy, and slender microvilli
containing adipose tissue and 
lymphoid 
19 Garg et al. Aggregates, areas of  No extension Stains positive for calretinin Numerous
mucin production, cells with  and strong staining for cytokeratin 5/6 long, bushy, and slender microvilli
a signet ringlike appearance
20 Garg et al. No extension Sains positive for calretinin Not done
21 Varkarakis et al. Tan nodular with sites  No extension Stains positive for calretinin Not done
of heterotopic ossification
22 Hamamatsu et al. White, solid, well-circumscribed, No extension Stained positive for calretinin, D2-40, Not done
and smooth vimentin, and cytokeratins 
(AE1/AE3, OV-TL 12/30, CAM 5.2, 
and MNF116
23 Timonera et al. Well-circumscribed, solid,  No extension Strongly positive for D2-40 and calretinin Not done
with variegated yellow  and weak reactivity for cytokeratin 5/6
and tan cut surface
24 Timonera et al. Well circumscribed, 
heterogeneous cystic and solid 
mass with hemorrhagic areas
Table 2 continued next page.[Rare Tumors 2011; 3:e21] [page 65]
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been  29  reported  cases  of  adenomatoid
tumors  of  the  adrenal  gland  in  the  recent
English-language  medical  literature.1-19
Almost  all  of  these  cases  were  in  male
patients  (97%)  with  a  mean  age  of
40Literature Review10 years (range=22-64).
The  laterality  of  these  tumors  is  approxi-
mately 14 (48%) tumors on the right side and
14 (48%) tumors on the left side (laterality
was unknown in one patient) with an aver-
age size of 4.6±4.0 cm (range=0.5-16.7 cm).
Many of these tumors were either discovered
as part of an autopsy or incidentally found as
part  of  a  diagnostic  work-up  for  various
symptoms  including:  painless  hematuria,
hypertension, abdominal pain, and Cushing’s
syndrome.  Various imaging modalities were
used  including  computed  tomography
(n=18), magnetic resonance imaging (n=6),
ultrasound  (n=3),  and  positron  emission
tomography (n=1). Interestingly, eight (31%)
patients  had  adenomatoid  tumors  that
extended into the periadrenal adipose tissue
or  the  adrenal  gland  capsule.  However,  no
recurrences have been reported with a medi-
an follow-up time of 33 months (range=3 to
177 months).
In terms of tumor color, these tumors have
been described as being white, tan, fleshy,
pale-yellow, opaque, and grayish. In terms of
tumor  consistency,  however,  these  tumors
have been described as being firm, smooth,
cystic,  solid,  and  well-circumscribed.  Other
histopathological  characteristics  have  been
noted in adenomatoid tumors including: het-
erotopic  ossification,  lymphoid  aggregates,
sites of mucin production, and cells with a
signet ring-like appearance.
Adenomatoid tumors have been found to
stain positive with a wide variety of agents
including: vimentin, calretinin, cytokeratins
(CAM 5.2, CKAE1, and CKAE3), MAK-6, D2-
40, OV-TL 12/30, and MNF 116.  A few studies
have  examined  adenomatoid  tumors  using
electron microscopy and found various fea-
tures including: numerous long, thin, bushy
microvilli with well developed desmosomes,
basal laminae, and cytoplasmic fibrillar net-
works.  
Discussion
Patients  with  human  immunodeficiency
virus (HIV) frequently present with a num-
ber of associated neoplasms, often as a result
of  their  immunosuppression.  It  is  very
unusual for HIV-positive patients to present
with  adrenal  gland  neoplasms  other  than
Kaposi’s sarcoma or lymphoma. HIV-positive
patients may also present with infectious eti-
ologies that may present as an adrenal mass,
including  cytomegalovirus  necrotizing
adrenalitis, mycobacterium, cryptococcus, or
other fungal infections.20,21 This case repre-
sents  only  the  second  reported  case  of  an
adenomatoid  tumor  in  a  patient  with  HIV.
However,  it  is  unknown  how  many  other
patients with reported adrenal adenomatoid
tumors  were  tested  for  HIV.    It  is  possible
Table 2. Continued from previous page.
# Author Tumor characteristics Tumor extension Histochemistry Electron microscopy
25 Fanet al. Ill-defined edge, smooth,  Focal infiltration of adrenal  Positive for cytokeratin 7, Not done
greyish-white, firm, with  cortex and medulla calretinin, vimentin, 
no hemorrhage or necrosis antimesothelial cell ab, 
and epithelial membrane antigen
26 Hoffman et al. Grey-whitish pattern of small cystic  No extension Positive for cytokeratin and calretinin, Not done
nodules with trabeculae but negative for CD31, CD34, and CD56
27 Biscegliaet al. Cystic, gray to pale yellowish with slight  No extension Positive to cytokeratins and calretinin,  Numerous small microvilli
mural thickening and short endoluminal  but negative to endothelial markers (coelomic or mesothelial type)
papillations
28 Liu et al. Ill-circumscribed multilocular cystic  Enveloped around the ipsilateral  Positive for calretinin and epithelial  Not done
tumor with tan wall with no hemorrhage  renal artery and vein membrane antigen,
or necrosis, cyst fluid was clear-yellow but negative for endothelial markers
29 Phitayakorn et al. Well circumscribed, tan-gray  No extension Stained positive for calretinin and cytokeratins  Not done
cortical mass (AE1/AE3 and CAM 5.2), and stained 
negative for CD31, CD34, and factor VIII.
Figure  1. The  tissue  at  far  right  in  this
image  is  normal  adrenal  cortical  tissue.
The  native  adrenal  tissue  is  replaced  or
extensively infiltrated by tumor cells form-
ing small solid nests as well as anastomos-
ing channels and tubules of variable size
and shape.
Figure 2. Lesional cells range from plump
epithelioid  cells  to  flattened  cells  resem-
bling endothelial cells, and many exhibit
prominent vacuolization, to an extent that
may mimic a signet-ring appearance with
apparent  intracytoplasmic  lumina.  They
do  not  exhibit  nuclear  pleomorphism,
necrosis or mitotic activity.
Figure 3. Immunostain for calretinin high-
lights the tumor cells, in keeping with their
mesothelial derivation.[page 66] [Rare Tumors 2011; 3:e21]
that  the  incidence  of  adrenal  adenomatoid
tumors in patients with HIV may increase as
a consequence of anti-retroviral therapies or
chronic immunosuppression.  
Although the first adenomatoid tumor was
described  in  1945,  adrenal  adenomatoid
tumors were not well described until the late
1980’s.22 This  result  may  be  due  to  the
increasing use of diagnostic computed tomo-
graphic  imaging  in  detecting  adrenal  inci-
dentalomas.  This  case  also  highlights  an
important caveat in that imaging techniques
such  as  computed  tomography  cannot  reli-
ably  distinguish  adrenal  adenomatoid
tumors  from  other  adrenocortical  tumors.5
Magnetic resonance imaging of the adrenal
adenomatoid tumor in this patient was more
consistent with a functional adrenal tumor.
Another  study  that  used  MRI  in  a  patient
with an adrenal adenomatoid noted that the
tumor was mainly solid with cystic peripher-
al  portions,  and  that  the  solid  areas  were
homogenously isointense to the spleen on all
images.5 In this particular case, the use of a
positron-emission  tomographic  (PET)  scan
was also not helpful in pre-operatively diag-
nosing  an  adrenal  adenomatoid  tumor.  In
fact, the level of 18F-FDG uptake of 3.4 SUV
was  in  the  range  of  malignant  adrenal
lesions.23
Finally,  this  case  emphasizes  that
although adrenal adenomatoid tumors have
been described in the past as extending into
the  perirenal  adipose  tissue,  the  clinical
behavior is definitely benign.10 Adrenal ade-
nomatoid  tumors  may  be  misclassified  as
lymphangiomas  or  adenocarcinomas
because of infiltrative borders into the adre-
nal capsule or periadrenal adipose tissue.24
These tumors can be reliably distinguished
from adrenal adenocarcinoma as adenoma-
toid tumors stain positive for keratin and do
not produce mucin.  Based on Table 1, local
resection limited to the adrenal gland itself
without any specific post-operative surveil-
lance protocol appears to be sufficient treat-
ment  of  adrenal  adenomatoid  tumors.
Laparoscopic  adrenalectomy  which  is  the
current gold-standard for the surgical resec-
tion  of  adrenal  tumors  can  be  safely
employed in the case of adrenal adenomatoid
tumors.
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